Literature DB >> 16830392

Treatment of solitary gastric carcinoid tumor by endoscopic polypectomy in a patient with pernicious anemia.

Gurhan Kadikoylu1, Irfan Yavasoglu, Vahit Yukselen, Esra Ozkara, Zahit Bolaman.   

Abstract

Type I gastric carcinoid tumors result from hypergastrinemia in 1%-7% of patients with pernicious anemia. We diagnosed pernicious anemia in a 48-year-old female patient with complaint of fatigue for three months. She had no gastrointestinal symptoms. Endoscopic examination ot the upper gastrointestinal tract revealed atrophic gastritis and a polypoid lesion in the corpus of 3-4 mm in size. Endoscopic polypectomy was performed. Histopathological examination of the specimen revealed positive chromogranin A and synaptophysin stainings compatible with the diagnosis of a carcinoid tumor. Serum gastrin level was increased, urinary 5-hydroxyindoleacetic acid was within the normal range. There was no other symptom, sign, or laboratory finding of a carcinoid syndrome in the patient. No metastasis was found with indium-111 octreotide scan, computed tomographies of abdomen and thorax. Type I gastric carcinoid tumors are only rarely solitary and patients with tumors < 1 cm in size may benefit from endoscopic polypectomy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830392      PMCID: PMC4087391          DOI: 10.3748/wjg.v12.i26.4267

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia.

Authors:  K Borch; H Renvall; G Liedberg
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

2.  [Multifocal gastric carcinoid associated with chronic type A atrophic gastritis. Analysis of 2 clinical cases].

Authors:  D Moneghini; M G Fontana; V Villanacci; B Salerni
Journal:  Ann Ital Chir       Date:  2001 Jan-Feb       Impact factor: 0.766

3.  Carcinoid tumors of the stomach: a clinical and radiographic study.

Authors:  A J Binstock; C D Johnson; D H Stephens; R V Lloyd; J G Fletcher
Journal:  AJR Am J Roentgenol       Date:  2001-04       Impact factor: 3.959

Review 4.  Neuroendocrine tumours: clinical presentation and management of localized disease.

Authors:  Matthew H Kulke
Journal:  Cancer Treat Rev       Date:  2003-10       Impact factor: 12.111

5.  Gastric carcinoids in patients with hypergastrinemia.

Authors:  Paul H Jordan; Alberto Barroso; John Sweeney
Journal:  J Am Coll Surg       Date:  2004-10       Impact factor: 6.113

6.  Gastric carcinoid tumors: radiographic features in eight cases.

Authors:  E J Balthazar; A Megibow; D Bryk; T Cohen
Journal:  AJR Am J Roentgenol       Date:  1982-12       Impact factor: 3.959

Review 7.  Carcinoid tumors of the stomach.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Surg Oncol       Date:  2003-08       Impact factor: 3.279

8.  Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study.

Authors:  Zahit Bolaman; Gurhan Kadikoylu; Vahit Yukselen; Irfan Yavasoglu; Sabri Barutca; Taskin Senturk
Journal:  Clin Ther       Date:  2003-12       Impact factor: 3.393

9.  Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.

Authors:  Gunnar Qvigstad; Tor Qvigstad; Bjørn Westre; Arne K Sandvik; Eiliv Brenna; Helge L Waldum
Journal:  APMIS       Date:  2002-02       Impact factor: 3.205

10.  Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia.

Authors:  W Ye; O Nyrén
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more
  6 in total

1.  Hypergastrinemia and recurrent type 1 gastric carcinoid in a young Indian male: necessity for antrectomy?

Authors:  Viplove Senadhi; Niraj Jani
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

Review 2.  Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor.

Authors:  Linda Zhang; Junko Ozao; Richard Warner; Celia Divino
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 3.  [Gastric neuroendocrine tumors. Endoscopic and surgical treatment].

Authors:  M B Niederle; B Niederle
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

Review 4.  Concomitant gastric carcinoid and gastrointestinal stromal tumors: a case report.

Authors:  Ying-Lung Lin; Chang-Kou Wei; Jui-Kun Chiang; An-Liang Chou; Chih-Wei Chen; Chih-En Tseng
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection.

Authors:  Hyung Hun Kim; Gwang Ha Kim; Ji Hyun Kim; Myung-Gyu Choi; Geun Am Song; Sung Eun Kim
Journal:  Gastroenterol Res Pract       Date:  2014-02-17       Impact factor: 2.260

6.  Esophageal Leiomyoma in Patients with Megaloblastic Anemia.

Authors:  Adil Coskun; Mustafa Unubol; Ozden Yukselen; Vahit Yukselen; Ahmet Aydin; Serdar Şen; Ali Onder Karaoglu
Journal:  Euroasian J Hepatogastroenterol       Date:  2014-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.